CIPO Patents = 12

EPO Patents = 3

Trademarks = 1

Forward Citations = 1

Loading Chart...

12 inventors (with patents filed for the assignee):

Minoru S H Ko (4 out of 12 patents)

Tomokazu Amano (2 out of 2 patents)

Tetsuya Hirata (1 out of 7 patents)

4. Shigeru B H Ko (1 out of 1 patent)

5. Minoru Sh Ko (0 patent)

6. Shigeru Bh Ko (0 patent)

7. Shigeru BH Ko (0 patent)

4 patents: Sort by Forward Citations

1. 11186621 - Methods for enhancing the pluripotency of stem cells (2021-11-30),

2. 11059869 - Compositions for enhancing the pluripotency of stem cells (2021-07-13),

3. 10273458 - ZSCAN4 as a marker for pancreatic stem cells and progenitor cells and use thereof (2019-04-30),

4. 9932560 - Use of Zscan4 and Zscan4-dependent genes for direct reprogramming of somatic cells (2018-04-03),

Elixirgen, LLC is a biotechnology company that specializes in providing innovative solutions for drug discovery and cell therapy. With expertise in induced pluripotent stem cell technology, Elixirgen offers high-quality products and services for researchers and pharmaceutical companies worldwide. Their mission is to accelerate scientific advancements and improve human health through cutting-edge biotechnology.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

4 Patents

#116 in Baltimore, MD

#872 in Maryland

#58,971 in US

Baltimore, MD, United States of America

Elixirgen, LLC

Forward Citations = 1

12 inventors:

Minoru S H Ko (4 out of 12 patents)

Tomokazu Amano (2 out of 2 patents)

Tetsuya Hirata (1 out of 7 patents)

4. Shigeru B H Ko (1 out of 1 patent)

5. Minoru Sh Ko (0 patent)

Please report any incorrect information to support@idiyas.com

12 patents (CIPO):

Please report any incorrect information to support@idiyas.com

3 patents (EPO):

Please report any incorrect information to support@idiyas.com